Michael Bishop, MD

Professor of medicine and director of Hematopoietic Stem Cell Transplantation Program at University of Chicago Medicine

Articles by Michael Bishop, MD

CAR T Therapy as a New Option in Non-Hodgkin Lymphoma: Michael R. Bishop, MD

November 5th 2021

The hematological oncologist from University of Chicago Medicine discussed chimeric antigen receptor T cells therapy in non-Hodgkin lymphoma.

CAR T-Cell Therapy for Hematologic Cancers: Michael Bishop, MD

ByMichael Bishop, MD

June 30th 2021

The professor of medicine and director of the Hematopoietic Stem Cell Transplantation Program at University of Chicago Medicine described the impact of CAR T-cell therapy on the hematologic cancer landscape.

Michael Bishop, MD

Articles by Michael Bishop, MD

CAR T Therapy as a New Option in Non-Hodgkin Lymphoma: Michael R. Bishop, MD

CAR T-Cell Therapy for Hematologic Cancers: Michael Bishop, MD

Latest Updated Articles

Trending on CGTlive®

CGTLive®’s Weekly Rewind – November 7, 2025

What Were the Most Significant Inflection Points or Breakthroughs in Cell and Gene Therapy?